Sharda Cropchem Ltd — earnings calls
2 quarters summarised from transcripts filed with the exchange, every statement cited. Newest first.
Sharda Cropchem reported Q1 FY27 revenue of Rs.1,074 crores, up 9% year-on-year, with EBITDA growing 25% to Rs.178 crores as gross margin expanded to 36.7% and EBITDA margin rose to 16.6%. Management said NAFTA, LATAM and rest of the world markets grew and improved profitability, while Europe softened due to distributor destocking linked to an unusual heatwave. The company reiterated its FY27 guidance of 10%-15% revenue growth and gross margins around 35%, and reported it remains debt-free with cash, bank and liquid investments of Rs.767 crores as of 30th June 2026.
Sharda Cropchem reported Q4 FY26 revenue growth of 13% to Rs 2,065 crores with EBITDA up 75% to Rs 513 crores and PAT up 57% to Rs 319 crores. For the full year, revenue grew 22% to Rs 5,268 crores, EBITDA grew 69% to Rs 1,040 crores, and PAT grew 124% to Rs 681 crores. Management discussed gross margin expansion, working capital improvement, product registrations, and provided commentary on regional performance and geopolitical impacts on sourcing and logistics.